GDUFA Research Outcomes
Data & AI
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to data analytics and artificial intelligence (AI) for generic product development and assessment, including the development of natural language processing (NLP) and machine learning (ML) tools
-
Use of Data Analytics Approaches to Support Regulatory Assessment – from FDA Perspective
Hu, Meng
-
Leveraging Artificial Intelligence (AI) and Machine Learning (ML) to Support Generic Drug Development and Regulatory Efficiency
Hu, Meng
-
Leveraging Artificial Intelligence (AI) and Machine Learning (ML) to Support Regulatory Efficiency ��� Current Progress
Hu, Meng
-
Utility of Artificial Intelligence to Facilitate the Development and Regulatory Assessment of Complex Generic Drugs
Hu, Meng
-
Development of a Data/Text Analytics Tool to Enhance Quality and Efficiency of Bioequivalence Assessment
Hu, Meng
-
Quantitative Methods for Determining Equivalence of Particle Size Distributions
Hu, Meng
-
Big Data Toolsets to Pharmacometrics: Application of Machine Learning for Time-to-Event Analysis
Hu, Meng
-
Equivalence Testing of Complex Particle Size Distribution Profiles Based on Earth Mover’s Distance
Hu, Meng
-
Predictive Analysis of First ANDA Submission for NCEs Based on Machine Learning Methodology
Hu, Meng
-
Prediction of the First ANDA Submission for NCEs Utilizing Machine Learning Methodology
Hu, Meng